Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
140,036,400
-
Total 13F shares
-
98,215,048
-
Share change
-
+8,148,158
-
Total reported value
-
$66,126,833
-
Price per share
-
$0.68
-
Number of holders
-
27
-
Value change
-
+$5,325,340
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q3 2024
As of 30 Sep 2024,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,215,048 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, Altium Capital Management LP, VANGUARD GROUP INC, Juniper Investment Company, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Crescent Grove Advisors, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.